| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.9 |